NDC 59051-9128 - ThyroKare
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59051-9128
- Package NDCs from labels
- 59051-9128-9
- Manufacturer
- Neogen Corporation-Mercer Rd | Peptido GmbH
- Effective date
- 2018-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ThyroKare - Neogen Corporation-Mercer Rd | Peptido GmbH | Neogen Corporation-Mercer Rd | Peptido GmbH | 2018-11-01 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59051-9128-9 | ThyroKare | 4536 g in 1 PAIL | Powder | 4536 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59051-9128 | THYROKARE (LEVOTHYROXINE SODIUM) POWDER [NEOGEN CORPORATION-MERCER RD] | 1 | 1 package rows | 20181102_f200780c-8532-43e3-bc97-c901ebddb1da.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 52cce695-4363-8a2c-e063-6294a90a1bbf | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 52cd19e4-a4b3-ecee-e063-6394a90ac33b | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | db5cba81-9ad5-42ad-ac9e-a967337630f2 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | d9ccea69-109d-44cf-927b-4ff67652b6a0 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 4f40db1e-3dd9-4c7b-93e6-64f0fd10d551 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 50978a14-fd72-4c76-927f-667a1f097b87 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | eb53dc23-8337-497e-b466-192f905563ed | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 6d65b528-f52b-4b5d-8b76-46fbd4576f99 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 3519c765-2077-4f23-8644-a6242ddbf743 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | c38c3c31-6834-4590-ace0-f525e5599f66 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | ac10b751-5195-4987-a841-400ae79730f0 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 83854522-f22e-491f-8392-c8b1f9441760 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 645c52bb-c46e-426e-91d4-151aeac975a7 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 65c8b305-8ffb-4aa5-aca1-f4e4ead71a9c | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 633b3f9c-9578-4e07-a515-aec1a8b65e92 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 0cffbc96-7a02-4538-9966-b69249be6eb2 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | e293dd94-b523-47a2-8bed-e6d99945ee59 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 776c8dbc-ca34-40f9-9730-4aa59f644703 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 5c1cf991-6177-499d-a9b8-63e5ca92eb79 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 775ef7ba-0b5b-40ba-ac7b-2aef121fe4f4 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.